Free Trial

Natixis Advisors LLC Has $10.34 Million Holdings in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Natixis Advisors LLC lifted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 8.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,476 shares of the company's stock after purchasing an additional 4,839 shares during the quarter. Natixis Advisors LLC owned about 0.05% of Clorox worth $10,341,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Lake Street Advisors Group LLC purchased a new stake in Clorox during the first quarter valued at about $250,000. Natixis raised its position in Clorox by 707.8% during the first quarter. Natixis now owns 13,175 shares of the company's stock valued at $2,017,000 after acquiring an additional 11,544 shares in the last quarter. EntryPoint Capital LLC bought a new position in Clorox during the first quarter valued at approximately $39,000. CreativeOne Wealth LLC bought a new position in Clorox during the first quarter valued at approximately $229,000. Finally, Advisors Asset Management Inc. raised its position in Clorox by 257.5% during the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company's stock valued at $1,719,000 after acquiring an additional 8,087 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on CLX. Citigroup increased their price target on Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a report on Friday, September 6th. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a report on Monday, November 4th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and increased their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI lowered their price target on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a report on Friday, October 11th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $155.00.

Check Out Our Latest Stock Report on CLX

Clorox Trading Up 0.0 %

Shares of Clorox stock traded up $0.08 during trading on Friday, hitting $169.23. 597,236 shares of the company were exchanged, compared to its average volume of 1,240,132. The firm has a market capitalization of $20.95 billion, a P/E ratio of 58.91, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.30. The firm's fifty day moving average price is $162.72 and its 200 day moving average price is $148.22. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm's revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 earnings per share. As a group, sell-side analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is 170.03%.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.57% of the company's stock.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should you invest $1,000 in Clorox right now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines